Loading…

Calcitriol attenuates vascular remodeling in association with alteration of ppET-1/[ET.sub.B]R/eNOS and [ET.sub.A]R expression in acute and chronic phases of kidney ischemia-reperfusion injury in mice

Kidney ischemia-reperfusion injury (IRI) causes acute kidney injury with increasing risk of maladaptive repair through endothelin-1 (ET-1)/endothelin type A receptor ([ET.sub.A]R) signaling. Calcitriol shows renoprotection in kidney fibrosis, however, its effects on vasoactive substances expression...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of physiology and pharmacology 2023-01, Vol.101 (1), p.8
Main Authors: Desita, Eryna Ayu Nugra, Arfian, Nur, Setyaningsih, Wiwit Ananda Wahyu, Sari, Dwi Cahyani Ratna
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page 8
container_title Canadian journal of physiology and pharmacology
container_volume 101
creator Desita, Eryna Ayu Nugra
Arfian, Nur
Setyaningsih, Wiwit Ananda Wahyu
Sari, Dwi Cahyani Ratna
description Kidney ischemia-reperfusion injury (IRI) causes acute kidney injury with increasing risk of maladaptive repair through endothelin-1 (ET-1)/endothelin type A receptor ([ET.sub.A]R) signaling. Calcitriol shows renoprotection in kidney fibrosis, however, its effects on vasoactive substances expression and vascular remodeling following kidney IRI remain unclear. This research aimed to investigate Calcitriol's effects on preproendothelin-1 (ppET-1), [ET.sub.A]R, endothelial nitric oxide synthase (eNOS) mRNA expression and vascular remodeling in acute and chronic phases of kidney IRI in mice. Twenty-five male Swiss mice were randomly divided into five groups (n = 5): SO (sham-operated), IR3 (3 day kidney IRI), IR12 (12 day kidney IRI), IRD3 (3 day kidney IRI + Calcitriol 0.5 pg/kg body weight (BW)/day), and IRD12 (12 day kidney IRI + Calcitriol 0.5 pg/kg BW/day). Ischemiareperfusion injury groups underwent bilateral renal pedicles clamping for 30 min, then reperfusion. Kidneys were harvested for Sirius Red staining to observe interstitial fibrosis and vascular remodeling, polymerase chain reaction to quantify ppET-1, endothelin type B receptor ([ET.sub.B]R), eNOS mRNA expression, and Western blotting to quantify [ET.sub.A]R protein expression. Calcitriol treatment in both phases of kidney IRI showed lower serum creatinine and [ET.sub.A]R protein expression, while higher eNOS and [ET.sub.B]R mRNA expression than IRI-only groups. Furthermore, ppET-1 mRNA expression was higher in IRD3 than IR3, but lower in IRD12 than IR12. Calcitriol also prevented vascular remodeling as indicated by lower wall thickness and higher lumen/wall area ratio than IRI-only groups.
doi_str_mv 10.1139/cjpp-2022-0130
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A735339743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A735339743</galeid><sourcerecordid>A735339743</sourcerecordid><originalsourceid>FETCH-LOGICAL-g2003-233649a0e0275d2be3aac0cd8570f2d1a24c0fef0562fb8ebb0380cd5de88d5b3</originalsourceid><addsrcrecordid>eNqVkE1vEzEQhi0EEqFw7dmCEwcn_tjNbo4hCqVS1UppOFVVNGvPbhw23sX20vYf8rNwaJFaKRfkgzUzz_toNIScCj4WQs0metf3THIpGReKvyIjIXnOijwTr8mIc16yTAr5lrwLYZfKaanKEfm9gFbb6G3XUogR3QARA_0FQQ8teOpx3xlsrWuodRRC6LSFaDtH72zcUmgj-se6q2nfL9dMTG6W63EYqvGX29UEL6-uKThD_zXntyuK973HEA6pg1QPEf8yeus7ZzXttxDSEsn4wxqHD9QGvcW9BeaxR18PT9Hd4B8Ohr3V-J68qaEN-OHpPyHfvy7Xi2_s4ursfDG_YI3kXDGp1DSbAUcui9zIChWA5tqUecFraQTITPMaa55PZV2VWFVclWmeGyxLk1fqhHx69DbQ4sa6uose9D5tuJkXKldqVmQqUewI1aBL12o7h7VN7Rf8xyO87u3PzXNofARKz6Tb6KPWzy8CiYl4HxsYQticX6_-g718zv4BMNHDCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Calcitriol attenuates vascular remodeling in association with alteration of ppET-1/[ET.sub.B]R/eNOS and [ET.sub.A]R expression in acute and chronic phases of kidney ischemia-reperfusion injury in mice</title><source>SPORTDiscus with Full Text</source><creator>Desita, Eryna Ayu Nugra ; Arfian, Nur ; Setyaningsih, Wiwit Ananda Wahyu ; Sari, Dwi Cahyani Ratna</creator><creatorcontrib>Desita, Eryna Ayu Nugra ; Arfian, Nur ; Setyaningsih, Wiwit Ananda Wahyu ; Sari, Dwi Cahyani Ratna</creatorcontrib><description>Kidney ischemia-reperfusion injury (IRI) causes acute kidney injury with increasing risk of maladaptive repair through endothelin-1 (ET-1)/endothelin type A receptor ([ET.sub.A]R) signaling. Calcitriol shows renoprotection in kidney fibrosis, however, its effects on vasoactive substances expression and vascular remodeling following kidney IRI remain unclear. This research aimed to investigate Calcitriol's effects on preproendothelin-1 (ppET-1), [ET.sub.A]R, endothelial nitric oxide synthase (eNOS) mRNA expression and vascular remodeling in acute and chronic phases of kidney IRI in mice. Twenty-five male Swiss mice were randomly divided into five groups (n = 5): SO (sham-operated), IR3 (3 day kidney IRI), IR12 (12 day kidney IRI), IRD3 (3 day kidney IRI + Calcitriol 0.5 pg/kg body weight (BW)/day), and IRD12 (12 day kidney IRI + Calcitriol 0.5 pg/kg BW/day). Ischemiareperfusion injury groups underwent bilateral renal pedicles clamping for 30 min, then reperfusion. Kidneys were harvested for Sirius Red staining to observe interstitial fibrosis and vascular remodeling, polymerase chain reaction to quantify ppET-1, endothelin type B receptor ([ET.sub.B]R), eNOS mRNA expression, and Western blotting to quantify [ET.sub.A]R protein expression. Calcitriol treatment in both phases of kidney IRI showed lower serum creatinine and [ET.sub.A]R protein expression, while higher eNOS and [ET.sub.B]R mRNA expression than IRI-only groups. Furthermore, ppET-1 mRNA expression was higher in IRD3 than IR3, but lower in IRD12 than IR12. Calcitriol also prevented vascular remodeling as indicated by lower wall thickness and higher lumen/wall area ratio than IRI-only groups.</description><identifier>ISSN: 0008-4212</identifier><identifier>EISSN: 1205-7541</identifier><identifier>DOI: 10.1139/cjpp-2022-0130</identifier><language>eng</language><publisher>NRC Research Press</publisher><subject>Analysis ; Calcitriol ; Care and treatment ; Chronic kidney failure ; Development and progression ; Dosage and administration ; Gene expression ; Messenger RNA ; Nitric oxide ; Prevention ; Properties ; Reperfusion injury ; Risk factors</subject><ispartof>Canadian journal of physiology and pharmacology, 2023-01, Vol.101 (1), p.8</ispartof><rights>COPYRIGHT 2023 NRC Research Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Desita, Eryna Ayu Nugra</creatorcontrib><creatorcontrib>Arfian, Nur</creatorcontrib><creatorcontrib>Setyaningsih, Wiwit Ananda Wahyu</creatorcontrib><creatorcontrib>Sari, Dwi Cahyani Ratna</creatorcontrib><title>Calcitriol attenuates vascular remodeling in association with alteration of ppET-1/[ET.sub.B]R/eNOS and [ET.sub.A]R expression in acute and chronic phases of kidney ischemia-reperfusion injury in mice</title><title>Canadian journal of physiology and pharmacology</title><description>Kidney ischemia-reperfusion injury (IRI) causes acute kidney injury with increasing risk of maladaptive repair through endothelin-1 (ET-1)/endothelin type A receptor ([ET.sub.A]R) signaling. Calcitriol shows renoprotection in kidney fibrosis, however, its effects on vasoactive substances expression and vascular remodeling following kidney IRI remain unclear. This research aimed to investigate Calcitriol's effects on preproendothelin-1 (ppET-1), [ET.sub.A]R, endothelial nitric oxide synthase (eNOS) mRNA expression and vascular remodeling in acute and chronic phases of kidney IRI in mice. Twenty-five male Swiss mice were randomly divided into five groups (n = 5): SO (sham-operated), IR3 (3 day kidney IRI), IR12 (12 day kidney IRI), IRD3 (3 day kidney IRI + Calcitriol 0.5 pg/kg body weight (BW)/day), and IRD12 (12 day kidney IRI + Calcitriol 0.5 pg/kg BW/day). Ischemiareperfusion injury groups underwent bilateral renal pedicles clamping for 30 min, then reperfusion. Kidneys were harvested for Sirius Red staining to observe interstitial fibrosis and vascular remodeling, polymerase chain reaction to quantify ppET-1, endothelin type B receptor ([ET.sub.B]R), eNOS mRNA expression, and Western blotting to quantify [ET.sub.A]R protein expression. Calcitriol treatment in both phases of kidney IRI showed lower serum creatinine and [ET.sub.A]R protein expression, while higher eNOS and [ET.sub.B]R mRNA expression than IRI-only groups. Furthermore, ppET-1 mRNA expression was higher in IRD3 than IR3, but lower in IRD12 than IR12. Calcitriol also prevented vascular remodeling as indicated by lower wall thickness and higher lumen/wall area ratio than IRI-only groups.</description><subject>Analysis</subject><subject>Calcitriol</subject><subject>Care and treatment</subject><subject>Chronic kidney failure</subject><subject>Development and progression</subject><subject>Dosage and administration</subject><subject>Gene expression</subject><subject>Messenger RNA</subject><subject>Nitric oxide</subject><subject>Prevention</subject><subject>Properties</subject><subject>Reperfusion injury</subject><subject>Risk factors</subject><issn>0008-4212</issn><issn>1205-7541</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqVkE1vEzEQhi0EEqFw7dmCEwcn_tjNbo4hCqVS1UppOFVVNGvPbhw23sX20vYf8rNwaJFaKRfkgzUzz_toNIScCj4WQs0metf3THIpGReKvyIjIXnOijwTr8mIc16yTAr5lrwLYZfKaanKEfm9gFbb6G3XUogR3QARA_0FQQ8teOpx3xlsrWuodRRC6LSFaDtH72zcUmgj-se6q2nfL9dMTG6W63EYqvGX29UEL6-uKThD_zXntyuK973HEA6pg1QPEf8yeus7ZzXttxDSEsn4wxqHD9QGvcW9BeaxR18PT9Hd4B8Ohr3V-J68qaEN-OHpPyHfvy7Xi2_s4ursfDG_YI3kXDGp1DSbAUcui9zIChWA5tqUecFraQTITPMaa55PZV2VWFVclWmeGyxLk1fqhHx69DbQ4sa6uose9D5tuJkXKldqVmQqUewI1aBL12o7h7VN7Rf8xyO87u3PzXNofARKz6Tb6KPWzy8CiYl4HxsYQticX6_-g718zv4BMNHDCQ</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Desita, Eryna Ayu Nugra</creator><creator>Arfian, Nur</creator><creator>Setyaningsih, Wiwit Ananda Wahyu</creator><creator>Sari, Dwi Cahyani Ratna</creator><general>NRC Research Press</general><scope>ISN</scope><scope>ISR</scope></search><sort><creationdate>20230101</creationdate><title>Calcitriol attenuates vascular remodeling in association with alteration of ppET-1/[ET.sub.B]R/eNOS and [ET.sub.A]R expression in acute and chronic phases of kidney ischemia-reperfusion injury in mice</title><author>Desita, Eryna Ayu Nugra ; Arfian, Nur ; Setyaningsih, Wiwit Ananda Wahyu ; Sari, Dwi Cahyani Ratna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g2003-233649a0e0275d2be3aac0cd8570f2d1a24c0fef0562fb8ebb0380cd5de88d5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Calcitriol</topic><topic>Care and treatment</topic><topic>Chronic kidney failure</topic><topic>Development and progression</topic><topic>Dosage and administration</topic><topic>Gene expression</topic><topic>Messenger RNA</topic><topic>Nitric oxide</topic><topic>Prevention</topic><topic>Properties</topic><topic>Reperfusion injury</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desita, Eryna Ayu Nugra</creatorcontrib><creatorcontrib>Arfian, Nur</creatorcontrib><creatorcontrib>Setyaningsih, Wiwit Ananda Wahyu</creatorcontrib><creatorcontrib>Sari, Dwi Cahyani Ratna</creatorcontrib><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><jtitle>Canadian journal of physiology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desita, Eryna Ayu Nugra</au><au>Arfian, Nur</au><au>Setyaningsih, Wiwit Ananda Wahyu</au><au>Sari, Dwi Cahyani Ratna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcitriol attenuates vascular remodeling in association with alteration of ppET-1/[ET.sub.B]R/eNOS and [ET.sub.A]R expression in acute and chronic phases of kidney ischemia-reperfusion injury in mice</atitle><jtitle>Canadian journal of physiology and pharmacology</jtitle><date>2023-01-01</date><risdate>2023</risdate><volume>101</volume><issue>1</issue><spage>8</spage><pages>8-</pages><issn>0008-4212</issn><eissn>1205-7541</eissn><abstract>Kidney ischemia-reperfusion injury (IRI) causes acute kidney injury with increasing risk of maladaptive repair through endothelin-1 (ET-1)/endothelin type A receptor ([ET.sub.A]R) signaling. Calcitriol shows renoprotection in kidney fibrosis, however, its effects on vasoactive substances expression and vascular remodeling following kidney IRI remain unclear. This research aimed to investigate Calcitriol's effects on preproendothelin-1 (ppET-1), [ET.sub.A]R, endothelial nitric oxide synthase (eNOS) mRNA expression and vascular remodeling in acute and chronic phases of kidney IRI in mice. Twenty-five male Swiss mice were randomly divided into five groups (n = 5): SO (sham-operated), IR3 (3 day kidney IRI), IR12 (12 day kidney IRI), IRD3 (3 day kidney IRI + Calcitriol 0.5 pg/kg body weight (BW)/day), and IRD12 (12 day kidney IRI + Calcitriol 0.5 pg/kg BW/day). Ischemiareperfusion injury groups underwent bilateral renal pedicles clamping for 30 min, then reperfusion. Kidneys were harvested for Sirius Red staining to observe interstitial fibrosis and vascular remodeling, polymerase chain reaction to quantify ppET-1, endothelin type B receptor ([ET.sub.B]R), eNOS mRNA expression, and Western blotting to quantify [ET.sub.A]R protein expression. Calcitriol treatment in both phases of kidney IRI showed lower serum creatinine and [ET.sub.A]R protein expression, while higher eNOS and [ET.sub.B]R mRNA expression than IRI-only groups. Furthermore, ppET-1 mRNA expression was higher in IRD3 than IR3, but lower in IRD12 than IR12. Calcitriol also prevented vascular remodeling as indicated by lower wall thickness and higher lumen/wall area ratio than IRI-only groups.</abstract><pub>NRC Research Press</pub><doi>10.1139/cjpp-2022-0130</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-4212
ispartof Canadian journal of physiology and pharmacology, 2023-01, Vol.101 (1), p.8
issn 0008-4212
1205-7541
language eng
recordid cdi_gale_infotracmisc_A735339743
source SPORTDiscus with Full Text
subjects Analysis
Calcitriol
Care and treatment
Chronic kidney failure
Development and progression
Dosage and administration
Gene expression
Messenger RNA
Nitric oxide
Prevention
Properties
Reperfusion injury
Risk factors
title Calcitriol attenuates vascular remodeling in association with alteration of ppET-1/[ET.sub.B]R/eNOS and [ET.sub.A]R expression in acute and chronic phases of kidney ischemia-reperfusion injury in mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A27%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcitriol%20attenuates%20vascular%20remodeling%20in%20association%20with%20alteration%20of%20ppET-1/%5BET.sub.B%5DR/eNOS%20and%20%5BET.sub.A%5DR%20expression%20in%20acute%20and%20chronic%20phases%20of%20kidney%20ischemia-reperfusion%20injury%20in%20mice&rft.jtitle=Canadian%20journal%20of%20physiology%20and%20pharmacology&rft.au=Desita,%20Eryna%20Ayu%20Nugra&rft.date=2023-01-01&rft.volume=101&rft.issue=1&rft.spage=8&rft.pages=8-&rft.issn=0008-4212&rft.eissn=1205-7541&rft_id=info:doi/10.1139/cjpp-2022-0130&rft_dat=%3Cgale%3EA735339743%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g2003-233649a0e0275d2be3aac0cd8570f2d1a24c0fef0562fb8ebb0380cd5de88d5b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A735339743&rfr_iscdi=true